Reginald Genechten - Biocartis Group Head Chain
| BCART Stock | EUR 0.29 0.00 0.00% |
Insider
Reginald Genechten is Head Chain of Biocartis Group NV
| Age | 57 |
| Phone | 32 1 563 20 00 |
| Web | https://www.biocartis.com |
Biocartis Group Management Efficiency
The company has return on total asset (ROA) of (0.2245) % which means that it has lost $0.2245 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (48.8364) %, meaning that it generated substantial loss on money invested by shareholders. Biocartis Group's management efficiency ratios could be used to measure how well Biocartis Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Antonio Bosque | ageas SANV | 60 | |
| Tom Hautekiet | NV Bekaert SA | N/A | |
| Gary Crist | ageas SANV | 66 | |
| Chris Sluys | Barco NV | 63 | |
| Serge Herck | EVS Broadcast Equipment | N/A | |
| Jerry Bata | ageas SANV | N/A | |
| Xavier Orri | EVS Broadcast Equipment | N/A | |
| Veerle Wit | EVS Broadcast Equipment | N/A | |
| Marc Spenle | Barco NV | 48 | |
| Juan Alonso | NV Bekaert SA | 45 | |
| Quentin Grutman | EVS Broadcast Equipment | N/A | |
| Michel Counson | EVS Broadcast Equipment | 63 | |
| Gunter Craen | NV Bekaert SA | N/A | |
| Thierry Delbrouck | EVS Broadcast Equipment | N/A | |
| Veerle Verbessem | ageas SANV | N/A | |
| Alex Redfern | EVS Broadcast Equipment | N/A | |
| Pierre Matelart | EVS Broadcast Equipment | N/A | |
| Filip Coremans | ageas SANV | 59 | |
| Anthony Huyghebaert | Barco NV | 49 | |
| Emmanuel Grimbergen | ageas SANV | 55 | |
| Christophe Boizard | ageas SANV | 64 | |
Management Performance
| Return On Equity | -48.84 | |||
| Return On Asset | -0.22 |
Biocartis Group NV Leadership Team
Elected by the shareholders, the Biocartis Group's board of directors comprises two types of representatives: Biocartis Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biocartis. The board's role is to monitor Biocartis Group's management team and ensure that shareholders' interests are well served. Biocartis Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biocartis Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Reginald Genechten, Head Chain | ||
| Benoit Devogelaere, Chief Officer | ||
| Erwin Sablon, Head Management | ||
| Geert Maertens, Chairman Officer | ||
| JeanMarc Roelandt, Chief Officer | ||
| Piet Houwen, Chief Officer | ||
| Renate Degrave, Head Communications | ||
| Herman Verrelst, CEO Director | ||
| Dirk Zimmermann, Global Partnering | ||
| Susy Spruyt, Head Organization |
Biocartis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biocartis Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -48.84 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (1.07) % | |||
| Operating Margin | (0.85) % | |||
| Current Valuation | 182.31 M | |||
| Shares Outstanding | 93.1 M | |||
| Shares Owned By Insiders | 6.66 % | |||
| Shares Owned By Institutions | 27.71 % | |||
| Price To Earning | (9.91) X | |||
| Price To Book | 6.47 X |
Pair Trading with Biocartis Group
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocartis Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocartis Group will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Biocartis Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocartis Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocartis Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocartis Group NV to buy it.
The correlation of Biocartis Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocartis Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocartis Group NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocartis Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Biocartis Stock
Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.